Reading Clinical Studies: 

Taking off the rose-coloured glasses - and the peril if we don't

Monday Lunch Livestream

With Associate Professor Nathan Cherny

2 December 2021

The generalisability and veracity of research findings from clinical studies can be undermined by issues in design, implementation, and analysis.

Hear Associate Professor Nathan Cherny, visiting from Shaare Zedek Medical Center, Jerusalem, for a structured, rational and guideline-driven approach to the interpretation of clinical trial results. The presentation highlights the perils of not using this approach in terms of scientific, societal, and reputational harms.

Associate Professor Nathan Cherny

Nathan Cherny is an Australian born and trained medical oncologist and palliative care physician who has been working at the Shaare Zedek Medical Center in Jerusalem since 1994. He has an active practice in general oncology and oncologic palliative care. 

Nathan is currently the Chair of the ESMO Magnitude of Clinical Benefit Working Group, former chair of the Palliative Care Working Group and current member of the ESMO guidelines steering committee and cancer medicine policy working group. He is also the senior editor of the Oxford Textbook of Palliative Medicine. He teaches in the Hebrew University Medical School and runs courses in communication and palliative medicine and a mentorship program for Palestinian oncologists from the West Bank and for the Al-sadeel Palliative Care Society in Bethlehem.

Nathan has edited six books and has published over 150 peer reviewed papers. His contributions have been widely recognised: he was the recipient of the ESMO award in 2015, the the Danielli award for humanistic care in oncology in 2016, Monash University Doctor of Laws Honoris Causa in 2017 and membership of the Order of Australia in 2019.